The application of polymer excipients in 3D printing manufacturing is usually limited due to the concerns of filament strength, high processing temperature and large-scale manufacturing. Latest technology developments are targeting a direct melt deposition to simplify the process and enable a constant and efficient process. Two different processing approaches will be presented: The advanced melt drop deposition, where individual three-dimensional geometries can be created by deposition of polymer droplets, and the MED® 3D printing technology which allows precise layer-by-layer deposition to produce objects with well-designed geometric structures.
In this webinar, you will learn:
- Latest advancements of melt-based 3D printing approaches
- Application examples for the individual technologies
- Deep dive in the MED® 3D printing technology to design dedicated drug release profiles
- Excipient requirements for 3D printing technology
Speakers
Thomas Kipping, Ph.D.
Merck
Head of Drug Carriers
Dr. Thomas Kipping is an expert in the field of pharmaceutical technology and formulation development. Thomas is currently the head of drug carriers at Merck. With more than 10 years of industrial experience, spanning various sectors within the pharmaceutical industry, including drug product development and CDMO services, he has consistently demonstrated a strong commitment to advancing pharmaceutical sciences and enhancing drug development processes He holds a Ph.D. in pharmaceutical technology from the University of Bonn.
Xianghao Zuo, Ph.D.
Triastek, Inc.
Deputy Director of R&D
Xianghao Zuo received his Ph.D. in materials science and engineering at Stony Brook University. He is now the deputy director of R&D at Triastek, Inc., specializing in developing 3D-printed drug products and improving the solubility and bioavailability of poorly soluble drugs.
Pharma and biopharma manufacturing
- Solid Formulation Strategies
기간:1h
언어:English
세션 1:발표 완료 June 23, 2022
계속 읽으시려면 로그인하거나 계정을 생성하세요.
계정이 없으십니까?